Second Sight
Second Sight manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence.
Launch date
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Jul 2014.)
Los Angeles California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $10.0m | Post IPO Equity | |
N/A | $5.0m | Post IPO Equity | |
$2.0m | Grant | ||
N/A | $4.0m | Post IPO Equity | |
Total Funding | €10.9m |
Related Content
Recent News about Second Sight
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.